CN105229153A - 细菌人工染色体 - Google Patents

细菌人工染色体 Download PDF

Info

Publication number
CN105229153A
CN105229153A CN201480023688.3A CN201480023688A CN105229153A CN 105229153 A CN105229153 A CN 105229153A CN 201480023688 A CN201480023688 A CN 201480023688A CN 105229153 A CN105229153 A CN 105229153A
Authority
CN
China
Prior art keywords
cdna
rna
viral
virus
bac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480023688.3A
Other languages
English (en)
Chinese (zh)
Inventor
K·达尔梅尔
J·内茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to CN202510130019.6A priority Critical patent/CN120249337A/zh
Publication of CN105229153A publication Critical patent/CN105229153A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CN201480023688.3A 2013-04-26 2014-04-25 细菌人工染色体 Pending CN105229153A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202510130019.6A CN120249337A (zh) 2013-04-26 2014-04-25 细菌人工染色体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1307528.8A GB201307528D0 (en) 2013-04-26 2013-04-26 Bacterial artificial chromosomes
GB1307528.8 2013-04-26
PCT/EP2014/058459 WO2014174078A1 (en) 2013-04-26 2014-04-25 Bacterial artificial chromosomes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202510130019.6A Division CN120249337A (zh) 2013-04-26 2014-04-25 细菌人工染色体

Publications (1)

Publication Number Publication Date
CN105229153A true CN105229153A (zh) 2016-01-06

Family

ID=48626864

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201480023688.3A Pending CN105229153A (zh) 2013-04-26 2014-04-25 细菌人工染色体
CN202510130019.6A Pending CN120249337A (zh) 2013-04-26 2014-04-25 细菌人工染色体

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202510130019.6A Pending CN120249337A (zh) 2013-04-26 2014-04-25 细菌人工染色体

Country Status (17)

Country Link
US (2) US10076564B2 (enExample)
EP (2) EP2989205B1 (enExample)
JP (1) JP6501756B2 (enExample)
KR (1) KR102170609B1 (enExample)
CN (2) CN105229153A (enExample)
AU (1) AU2014259354B2 (enExample)
BR (1) BR112015026531B1 (enExample)
DK (1) DK2989205T3 (enExample)
ES (1) ES2718187T3 (enExample)
GB (1) GB201307528D0 (enExample)
HU (1) HUE042886T2 (enExample)
PL (1) PL2989205T3 (enExample)
PT (1) PT2989205T (enExample)
SI (1) SI2989205T1 (enExample)
TR (1) TR201904215T4 (enExample)
WO (1) WO2014174078A1 (enExample)
ZA (1) ZA201507795B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164582A (zh) * 2018-09-07 2021-07-23 勒芬天主教大学 嵌合黄病毒丽沙病毒疫苗
CN114450408A (zh) * 2019-09-25 2022-05-06 鲁汶天主教大学 大载体和用于高产量生产的方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201716254D0 (en) 2017-10-05 2017-11-22 Univ Leuven Kath Live-attenuated flaviruses with heterologous antigens
GB201716307D0 (en) 2017-10-05 2017-11-22 Univ Leuven Kath Chimeric yellow fever zika virus strain
WO2019204654A1 (en) * 2018-04-18 2019-10-24 Utah State University Compositions and methods for zika virus characterization and vaccine development
MX2021012424A (es) 2019-04-10 2022-02-10 Univ Leuven Kath Virus quimérico de zika-encefalitis japonesa.
BR112022004378A2 (pt) 2019-09-13 2022-06-07 Univ Leuven Kath Vacinas para vírus lassa
WO2021048003A1 (en) 2019-09-13 2021-03-18 Katholieke Universiteit Leuven Chimeric filovirus vaccines
AU2021225362A1 (en) * 2020-02-27 2022-09-15 Katholieke Universiteit Leuven Coronavirus vaccines
WO2025012350A1 (en) * 2023-07-11 2025-01-16 Virovet Nv Vectors expressing attenuated rna virus of the family arteriviridae and uses thereof
WO2025171062A1 (en) * 2024-02-06 2025-08-14 The Regents Of The University Of California iMODULON GENE CLUSTERS AND METHODS TO IDENTIFY AND USE SAME

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101864442A (zh) * 2010-05-19 2010-10-20 江苏省农业科学院 重组火鸡疱疹病毒细菌人工染色体转移载体

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665600A (en) 1991-09-18 1997-09-09 Research Corporation Technologies, Inc. Pichia pastoris linear plasmids and DNA fragments thereof
US5866404A (en) 1995-12-06 1999-02-02 Yale University Yeast-bacteria shuttle vector
US6962708B1 (en) * 1997-02-28 2005-11-08 Acambis, Inc. Chimeric flavivirus vaccines
US5874259A (en) * 1997-11-21 1999-02-23 Wisconsin Alumni Research Foundation Conditionally amplifiable BAC vector
WO2000034497A2 (en) 1998-12-09 2000-06-15 The General Hospital Corporation Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
GB2372991B (en) * 2001-03-09 2004-11-17 Fiocruz Fundacao Oswaldo Cruz Flavivirus expression vector
US6472177B1 (en) 2001-04-23 2002-10-29 Wisconsin Alumni Research Foundation Expression vector with dual control of replication and transcription
US6864087B2 (en) * 2001-07-31 2005-03-08 Wisconsin Alumni Research Foundation Method for converting single-copy BAC vectors to conditional high-copy pBAC/oriHC vectors
US20050106733A1 (en) 2001-12-25 2005-05-19 Kenzo Takada Double-stranded cyclic dna capable of proliferating as a bacterial e coli chromosome
WO2004033633A2 (en) 2002-10-04 2004-04-22 Embiosis Pharmaceuticals Compatible host/vector systems for expression of dna
US20070036827A1 (en) 2003-10-29 2007-02-15 The University Of Queensland West nile virus vaccine
US20050214838A1 (en) 2004-03-10 2005-09-29 Waclaw Szybalski Methods for mapping and sequencing nucleic acids
WO2009053988A1 (en) 2007-10-25 2009-04-30 Ramot At Tel-Aviv University Ltd. Production of bac vectors carrying viral genomes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101864442A (zh) * 2010-05-19 2010-10-20 江苏省农业科学院 重组火鸡疱疹病毒细菌人工染色体转移载体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DENNIS J. PIERRO ET AL.: "Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional E6 mutation", 《JOURNAL OF GENERAL VIROLOGY》 *
JADWIGA WILD ET AL.: "conditionally amplifiable BACs：Switching from single-copy to high-copy vectors and genomic clones", 《GENOME RESEARCH》 *
杨承槐等: "细菌人工染色体及其在马立克氏病病毒研究中的应用", 《中国兽药杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164582A (zh) * 2018-09-07 2021-07-23 勒芬天主教大学 嵌合黄病毒丽沙病毒疫苗
CN114450408A (zh) * 2019-09-25 2022-05-06 鲁汶天主教大学 大载体和用于高产量生产的方法

Also Published As

Publication number Publication date
EP3540065A1 (en) 2019-09-18
SI2989205T1 (sl) 2019-05-31
AU2014259354B2 (en) 2020-02-27
ES2718187T3 (es) 2019-06-28
GB201307528D0 (en) 2013-06-12
EP2989205A1 (en) 2016-03-02
US20160206723A1 (en) 2016-07-21
US10076564B2 (en) 2018-09-18
BR112015026531A2 (enExample) 2017-09-05
WO2014174078A1 (en) 2014-10-30
CN120249337A (zh) 2025-07-04
EP2989205B1 (en) 2019-01-02
KR102170609B1 (ko) 2020-10-28
HUE042886T2 (hu) 2019-07-29
JP2016518132A (ja) 2016-06-23
TR201904215T4 (tr) 2019-04-22
PL2989205T3 (pl) 2019-06-28
ZA201507795B (en) 2019-07-31
AU2014259354A1 (en) 2015-11-05
BR112015026531B1 (pt) 2023-02-07
KR20160003032A (ko) 2016-01-08
US20190111125A1 (en) 2019-04-18
JP6501756B2 (ja) 2019-04-17
DK2989205T3 (en) 2019-04-23
PT2989205T (pt) 2019-04-23

Similar Documents

Publication Publication Date Title
EP2989205B1 (en) Bacterial artificial chromosomes
CN104159609B (zh) 用于预防锦鲤疱疹病毒(khv)引起的疾病的重组khv和疫苗
US20250057932A1 (en) Vaccines against infectious diseases caused by positive stranded rna viruses
AU2003267851B2 (en) Novel full-length genomic RNA of Japanese encephalitis virus, infectious JEV CDNA therefrom, and use thereof
Nickols et al. Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice
US20060280757A1 (en) Flavivirus vaccine delivery system
AU2018344508B2 (en) Live-attenuated flaviruses with heterologous antigens
AU2005279303B2 (en) Nucleic acid sequences encoding proteins capable of associating into a virus-like particle
US20230203536A1 (en) Coronavirus rna replicons and use thereof as vaccines
AU2004245578B2 (en) Flavivirus replicon packaging system
US20220257747A1 (en) Methods and compositions of astrovirus replicons
CN111615398A (zh) 嵌合黄热病寨卡病毒株

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160106

RJ01 Rejection of invention patent application after publication